Garland Capital Management Inc has filed its 13F form on April 30, 2024 for Q1 2024 where it was disclosed a total value porftolio of $151 Million distributed in 33 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jpmorgan Chase & CO with a value of $9.11M, Merck & Co., Inc. with a value of $8.25M, Abb Vie Inc. with a value of $8.13M, Travelers Companies, Inc. with a value of $7.01M, and Procter & Gamble CO with a value of $6.83M.

Examining the 13F form we can see an increase of $8.55M in the current position value, from $142M to 151M.

Below you can find more details about Garland Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $151 Million
Healthcare: $39 Million
Financial Services: $31.4 Million
Technology: $16.3 Million
Real Estate: $15.9 Million
Industrials: $14.2 Million
Consumer Defensive: $12.5 Million
Energy: $9.3 Million
Communication Services: $4.24 Million
Other: $8.05 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History


  • Portfolio
  • No. of Stocks 33
  • Current Value $151 Million
  • Prior Value $142 Million
  • Filing
  • Period Q1 2024
  • Filing Date April 30, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Garland Capital Management Inc Portfolio

Follow Garland Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.


Stay updated on Garland Capital Management Inc with notifications on news.